Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Medtronic
Merck
Baxter
Harvard Business School

Last Updated: January 27, 2023

Dasiglucagon hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for dasiglucagon hydrochloride and what is the scope of patent protection?

Dasiglucagon hydrochloride is the generic ingredient in two branded drugs marketed by Zealand Pharma and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Dasiglucagon hydrochloride has thirty-three patent family members in twenty-four countries.

One supplier is listed for this compound.

Summary for dasiglucagon hydrochloride
International Patents:33
US Patents:1
Tradenames:2
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Clinical Trials: 20
DailyMed Link:dasiglucagon hydrochloride at DailyMed
Recent Clinical Trials for dasiglucagon hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Inreda Diabetic B.V.Phase 2
Filip Krag KnopPhase 2
Steno Diabetes Center CopenhagenPhase 2

See all dasiglucagon hydrochloride clinical trials

Pharmacology for dasiglucagon hydrochloride

US Patents and Regulatory Information for dasiglucagon hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zealand Pharma ZEGALOGUE dasiglucagon hydrochloride SOLUTION;SUBCUTANEOUS 214231-001 Mar 22, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Zealand Pharma ZEGALOGUE (AUTOINJECTOR) dasiglucagon hydrochloride SOLUTION;SUBCUTANEOUS 214231-002 Mar 22, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Zealand Pharma ZEGALOGUE dasiglucagon hydrochloride SOLUTION;SUBCUTANEOUS 214231-001 Mar 22, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Zealand Pharma ZEGALOGUE (AUTOINJECTOR) dasiglucagon hydrochloride SOLUTION;SUBCUTANEOUS 214231-002 Mar 22, 2021 RX Yes Yes See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for dasiglucagon hydrochloride

Country Patent Number Title Estimated Expiration
South Korea 20200080331 글루카곤 유사체 (GLUCAGON ANALOGUES) See Plans and Pricing
Eurasian Patent Organization 033399 АНАЛОГИ ГЛЮКАГОНА С ПОВЫШЕННОЙ РАСТВОРИМОСТЬЮ И/ИЛИ СТАБИЛЬНОСТЬЮ И ИХ ПРИМЕНЕНИЕ (GLUCAGON ANALOGUES WITH INCREASED SOLUBILITY AND/OR STABILITY AND USE THEREOF) See Plans and Pricing
Japan 6534927 See Plans and Pricing
Canada 2878991 ANALOGUES DU GLUCAGON (GLUCAGON ANALOGUES) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Boehringer Ingelheim
Colorcon
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.